Balchem CORP 8-K filings

Balchem Corporation announced record net sales, net earnings, and adjusted EBITDA for the second quarter of 2026, driven by strong performance across all three reporting segments.

Balchem Corporation announced an amendment to its credit agreement, increasing the revolving commitment amount and extending the maturity date.

Balchem Corporation announced record first quarter net sales, adjusted EBITDA, and net earnings, with growth across all three business segments.

Balchem Corporation announced record net sales, adjusted EBITDA, and free cash flow for both the fourth quarter and full year ended December 31, 2025, driven by growth across all segments.

Balchem Corporation announced the election of Erin L. Gilson as its new Vice President and Chief Accounting Officer, effective April 1, 2026, succeeding William A. Backus upon his retirement.

Balchem Corporation announced a 10.3% increase in its annual dividend to $0.96 per share and a new stock repurchase program for up to 4 million shares.

Balchem Corporation announced record net sales of $267.6 million and a 19.1% increase in GAAP net earnings for the third quarter of 2025, driven by strong growth across all segments.

Balchem Corporation announced record net sales, adjusted EBITDA, and earnings per share for the second quarter of 2025, fueled by strong growth across all reporting segments and strategic advancements.

Balchem Corporation announced the successful re-election of three Class 1 directors, the ratification of RSM US LLP as its independent auditor, and the advisory approval of executive compensation at its Annual Meeting of Shareholders held on June 18, 2025.

Balchem Corporation announced record net sales and adjusted EBITDA for the first quarter of 2025, with growth across all three segments.

Balchem Corporation announced the retirement of Vice President and Chief Accounting Officer, William A. Backus, effective March 31, 2026.

Balchem Corporation announced record fourth quarter and full year 2024 financial results, with growth across all segments and increased profitability.

Balchem Corporation's Compensation Committee approves a new Executive Severance Policy and a deferred compensation matching program for executive officers.

Balchem Corporation's Board of Directors has declared a dividend of $0.87 per share, marking a 10.1% increase over last year's annual dividend.

Balchem Corporation announced robust third-quarter 2024 financial results, highlighted by solid revenue growth and record earnings.

Joyce Lee has resigned from the Balchem Corporation Board of Directors due to a planned change in her principal employment.

Balchem Corporation reclassified its board members to ensure each class has a near equal number of directors and amended its bylaws to change how board vacancies are filled.

Balchem Corporation announced solid second-quarter 2024 financial results, highlighted by record earnings from operations and adjusted EBITDA, driven by strong performance in the Human Nutrition and Health and Specialty Products segments.

Balchem Corporation held its annual shareholder meeting on June 20, 2024, where shareholders voted on the election of directors, ratification of the auditor, and executive compensation.

Balchem Corporation reported record net sales, adjusted EBITDA, and net earnings for the first quarter of 2024, driven by strong performance in its Human Nutrition & Health segment.

Balchem Corporation has announced changes to its executive leadership team, with Jonathan H. Griffin moving to Senior Vice President, Corporate Development, and C. Martin Bengtsson expanding his role to include leadership of the Animal Nutrition and Health segment.

Balchem Corporation announced its fourth quarter and full year 2023 financial results, highlighting record adjusted EBITDA and free cash flow despite a challenging demand environment.